Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$97,230,668
-$6,590,310 QoQ
Shares Held
1,192,868
-28.0% QoQ
Ownership
0.844%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ARWR ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,230,668 | 1,192,868 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $103,820,978 | 1,655,837 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $89,377,998 | 1,346,257 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $45,236,735 | 1,311,590 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $20,098,641 | 1,272,066 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $15,425,754 | 1,210,813 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $27,907,076 | 1,484,419 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $25,815,656 | 1,332,765 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $34,377,438 | 1,322,718 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $37,198,559 | 1,300,649 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $37,626,218 | 1,229,615 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $34,033,567 | 1,266,601 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $46,296,770 | 1,298,283 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $33,527,796 | 1,319,992 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $52,070,926 | 1,283,800 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $42,272,799 | 1,279,056 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $45,637,193 | 1,296,143 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $63,714,268 | 1,385,394 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $94,288,477 | 1,422,149 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $90,145,860 | 1,443,951 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $123,487,764 | 1,491,038 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $102,519,767 | 1,546,068 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $119,577,947 | 1,558,425 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $68,693,960 | 1,595,308 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $72,764,868 | 1,684,762 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $46,583,950 | 1,619,185 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||